A perfusion-based model to explain how paclitaxel achieves tumour-selective killing
Philip J. Murray, Adrian Thomas Saurin
This paper develops a mathematical model to explain how paclitaxel selectively kills tumour cells by exploiting differences in perfusion and drug retention between tumour and healthy tissues.